CEO and Founder
CYNBIOSE
Mablink Bioscience is a biotechnology company focused on developing targeted therapies for chronic diseases, utilizing advanced bioconjugation techniques to enhance drug delivery and efficacy. The company addresses the challenge of limited treatment options for patients with complex health conditions by creating more effective and accessible therapeutic solutions.
- Biotechnology
Updated 7 months ago
Funding
Raised to date
$2.1MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- Mablink Bioscience is a biotechnology company focused on developing targeted therapies for chronic diseases, utilizing advanced bioconjugation techniques to enhance drug delivery and efficacy. The company addresses the challenge of limited treatment options for patients with complex health conditions by creating more effective and accessible therapeutic solutions.